Royal Queen Seeds Releases Firsthand Accounts of New F1 Hybrid Seeds
International seed bank Royal Queen Seeds recently shared feedback from the first growers of their new F1 hybrid seeds.
After debuting their new F1 hybrid seeds earlier this year (1), international seed bank Royal Queen Seeds (RQS) shared results from releasing these seeds to homegrowers.
“Many cannabis seed companies market their seeds as F1 hybrids,” RQS said in a recent statement (2). “In the world of breeding, the term ‘F1’ simply describes the plants that make up the first generation following a cross. However, the majority of modern cannabis strains are created using unstable parents. This means they display inferior uniformity and lack the vigour of true F1 hybrids.”
According to RQS, the first wave of growers of their new hybrid seeds noted the speed of the plants’ maturation, size, and predictability of shape, among other aspects (2). “Impressive potency and high resin production,” stated one review that RQS highlighted (2). “Hard and full with a wonderful smell,” was part of another highlighted review (2).
RQS stated that the new F1 hybrid plants will produce more tetrahydrocannabinol (THC) and terpenes and will also be less prone to disease (2).
References
- McEvoy, E. Royal Queen Seeds presented new F1 hybrids to industry https://www.cannabissciencetech.com/view/royal-queen-seeds-presented-new-f1-hybrids-to-industry (accessed Jun 23, 2023).
- Royal Queen seeds USA https://www.royalqueenseeds.com/us/ (accessed Jun 23, 2023).
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
